leadf
logo-loader
viewCreso Pharma Ltd

Creso Pharma second Pharma Dynamics purchase order highlights South African opportunities

The order for cannaQIX® product is being sold under the Cannamics brand in South Africa and follows its successful launch in March 2020.

Creso Pharma Ltd - Creso Pharma second Pharma Dynamics purchase order highlights South African opportunities
The order further boosts Creso Pharma’s growing revenue profile

Creso Pharma Ltd (ASX:CPH) (FRA:1X) has secured a second purchase order from Lupin Ltd’s (NYSE:LUPIN) subsidiary, Pharma Dynamics South Africa worth around A$296,000.

The order for its cannaQIX® product is being sold under the Cannamics brand in South Africa and follows its successful launch into the South African market through Pharma Dynamics in March 2020.

The order further boosts Creso Pharma’s growing revenue profile, with a total of A$630,000 in sales generated since September from South Africa alone.

The company said multiple expansion initiatives were pending, with additional near-term purchase orders anticipated.

Further capitalising on opportunities

Creso Pharma’s chairman Adam Blumenthal said: “Securing this latest purchase order with Pharma Dynamics is a significant development and highlights the multiple opportunities we are witnessing in the region.

“Creso Pharma is beginning to see a trend in repeat orders from its clients globally which reinforces Creso’s high-quality products.

“The demand for our product on a global scale vindicates the market share initiatives we have put in place, and recent sales in Africa and Canada show that this strategy is not only growing the company’s footprint but also generating significant revenue.

“We look forward to further capitalising on these opportunities in the near-term.”

Pharma Dynamics chief executive officer Erik Roos added: “We are very happy to benefit from a very successful launch of Cannamics in South Africa, laying the foundation for the successful expansion into the other African countries that we serve.

“So far, customers report an excellent experience with Cannamics in terms of enhancing daily quality of life.”

Multiple expansion initiatives pending

Creso Pharma is also witnessing a robust business development pipeline grow, which will assist the company in securing additional purchase orders through its ongoing global expansion initiatives.

Additional purchase orders from a number of parties are pending, which will further underpin its growing revenue profile.

Pharma Dynamics deal

Under the agreement between the two parties, Pharma Dynamics distributes Creso Pharma’s hemp-based products across South Africa.

It is actively progressing plans to extend the distribution to Namibia, Botswana, Zimbabwe, Swaziland, Lesotho, Angola, Mozambique and Uganda.

Pharma Dynamics is a leading pharmaceutical company in South Africa and is ranked the fifth biggest generic pharmaceutical company in South Africa.

The company leads with high-quality generics at affordable prices and is well known for its investments into innovative wellness programs towards holistic healthcare.

It has a growing range of over-the-counter products and their products are consistently prescribed and recommended by doctors and pharmacists countrywide.

Quick facts: Creso Pharma Ltd

Price: 0.036 AUD

ASX:CPH
Market: ASX
Market Cap: $24.78 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Creso Pharma Ltd named herein, including the promotion by the Company of Creso Pharma Ltd in any Content on the Site, the Company receives from...

FOR OUR FULL DISCLAIMER CLICK HERE

Creso Pharma subsidiary Mernova granted sales license from Health Canada

Creso Pharma (ASX:CPH) subsidiary Mernova managing director Jack Yu and vice president Isaac Allen joined Steve Darling from Proactive to discuss the granting of their sales license from Health Canada and what it allows them to do. Isaac Allen tells Proactive they are gearing up sales...

on 12/6/20

3 min read